Laman UtamaRGLS • NASDAQ
add
Regulus Therapeutics Inc
$1.78
Selepas Waktu Dagangan:(7.30%)-0.13
$1.65
Tutup: 11 Apr, 5:49:14 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.72
Julat hari
$1.63 - $1.84
Julat tahun
$0.83 - $2.90
Permodalan pasaran
117.91J USD
Bilangan Purata
1.72J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Perihal
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Diasaskan
Sep 2007
Tapak web
Pekerja
34
